Neurotherapeutics 7 , 100114 (2010)
By the time you notice tingling feet, fatigue, brain fog, or balance issues, the deficiency has been silently progressing for months or years
Although amylase and lipase levels were numerically higher in the dulaglutide group during follow-up, clinically significant pancreatitis was rare, with only one case observed, likely related to gallstone disease rather than direct pharmacologic toxicity
10.1097/WNR.0b013e32832fbf14 20
This is usually mild but should be reported immediately if it occurs." Ongoing Monitoring At Each Follow-Up Visit: Ask specifically about tingling, numbness, burning sensations Check sensation in hands and feet Document any new symptoms Assess impact on quality of life Consider Dose Reduction If: Mild dysesthesia present but tolerable Patient achieving good weight loss (can afford slightly less efficacy) Symptoms are bothersome but not severe Consider Discontinuation If: Moderate to severe dysesthesia Progressive symptoms despite dose reduction Functional impairment Patient preference to stop Long-Term Unknowns and Research Needs Critical Questions for Future Studies 1